NEW YORK (GenomeWeb News) – Fluidigm intends to significantly expand its sales staff, particularly in North America, over the next two years, President and CEO Gajus Worthington told GenomeWeb Daily News this week.

"Our goal is to quadruple the size of our US sales operations over the next two years," he said. "The goal is to get the total size of that operation to 60 people.

"The reason that we're doing it is the business has expanded dramatically, even against the backdrop of the recession, and particularly in North America," said Worthington.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.